Sign In
Buy CCXI
$10.24
+0.0150 (+0.147%)
At Close: Jun 03, 2026
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
03:05pm, Thursday, 06'th May 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $CCXI #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI
New York, New York--(Newsfile Corp. - May 6, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securit
CCXI INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc.
01:20pm, Thursday, 06'th May 2021
NEW YORK, May 6, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who pu
RADNOR, Pa., May 6, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: C
Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ChemoC
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ChemoCentryx, Inc. (NASDA
Boston, Massachusetts--(Newsfile Corp. - May 6, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
10:26pm, Wednesday, 05'th May 2021
NEW YORK, May 5, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investors are ad
CCXI INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
07:29pm, Wednesday, 05'th May 2021
San Francisco, California--(Newsfile Corp. - May 5, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class
Ademi LLP Investigates Claims of Securities Fraud against ChemoCentryx Inc.
01:16pm, Wednesday, 05'th May 2021
MILWAUKEE, May 5, 2021 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against ChemoCentryx (NASDAQ: CCXI). The investigation results from inaccurate statements ChemoCentr
SAN FRANCISCO, May 5, 2021 /PRNewswire/ -- Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. The firm is investigating possible secu
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CCXI--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc.
Why ChemoCentryx Stock Crashed Today
04:06pm, Tuesday, 04'th May 2021
The FDA's briefing documents for an advisory committee don't appear to bode well for avacopan's chances of approval.
Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today
01:45pm, Tuesday, 04'th May 2021
Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc. (NASDAQ: STIM) and BioLineRx Ltd. (NASDAQ: BLRX) are among the biggest health care movers Tuesday.
Boston, Massachusetts--(Newsfile Corp. - May 4, 2021) - Block & Leviton LLP announces that the firm is investigating whether ChemoCentryx, Inc. (NASDAQ: CCXI) committed securities fraud. Investors who
